Zyprexa documents ppt 2.
This powerpoint has a selection of
pages from documents to do with
marketing issues.
ZY 100175096
Viva Zyprexa
ZY 100175096 Viva Zyprexa
PCPs/GPs = financial opportunities
ZY 100175096 Viva Zyprexa
Unmet needs/disease-mongering
ZY 100175096 Viva Zyprexa
Unmet needs/disease-mongering
ZY 100175096 Viva Zyprexa
Unmet needs/disease-mongering
ZY 100175096 Viva Zyprexa
Unmet needs/disease-mongering
ZY 100175096 Viva Zyprexa
Incentives to sales reps
ZY 100175096 Viva Zyprexa
Physician type casting & targeting
ZY 100175096 Viva Zyprexa
Physician CME strategy
ZY 100175096 Viva Zyprexa
Have the “customers” got the message?
ZY 100175096 Viva Zyprexa
studying and utilising the “customers”
ZY 100175096 Viva Zyprexa
To the tune of
“Viva Las
Vegas”
ZY100040517 Primary Care sales
video
ZY100040517 Primary Care sales
video
ZY100040517 Primary Care sales
video
ZY100040517 Primary Care sales
video
ZY100040668 PCP strategy manual
ZY100040668 PCP strategy manual
ZY100040668 PCP strategy manual
ZY100040668 PCP strategy manual
ZY100040668 PCP strategy manual
ZY200307990 Lilly exec comments to media re off-label marketing dwarfing schizophrenia
opportunities plus media comments re CME
newspaper article Mar 2003
ZY200307990 Lilly exec comments to media re off-label marketing dwarfing schizophrenia
opportunities plus media comments re CME
newspaper article Mar 2003
ZY200307990 Lilly exec comments to media re off-label marketing dwarfing schizophrenia
opportunities plus media comments re CME
newspaper article Mar 2003
ZY200307990 Lilly exec comments to media re off-label marketing dwarfing schizophrenia
opportunities plus media comments re CME
newspaper article Mar 2003
ZY100520636 Primary care implementation guide
June 2001
ZY100520636 Primary care implementation guide
June 2001
ZY100520636 Primary care implementation guide
June 2001
ZY100520636 Primary care implementation guide
June 2001
ZY100520636 Primary care implementation guide June 2001
ZY100520636 Primary care implementation guide June 2001
ZY100520636 Primary care implementation guide June 2001
ZY201220087 APA 2002 preparation
ZY201220087 APA 2002 preparation
ZY201220087 APA 2002 preparation
ZY201220087 APA 2002 preparation
ZY201220087 APA 2002 preparation
ZY201558654 “Competitive literature review” May 2002
• Document includes
numerous studies by
independent researchers
and competitor pharma
companies re
hypergylcaemia, diabetes
and hyperlipidaemia.
• Are “reviewed” in
(hyper)critical manner to
be found in error.
• Underlying theory seems to
be Zyprexa can’t cause
these problems.
ZY201220087 APA 2002 preparation
ZY100014182 APA 2003 review